3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
2
Neoplasms
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Post-operative Ileus
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Gallbladder Neoplasms
1
Disease
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Gastric Carcinoma
1
Interventions
Surveys and Questionnaires
86
Blood Specimen Collection
58
Interviews as Topic
28
Observation
15
Data Collection
15
Radiotherapy
12
Watchful Waiting
11
Magnetic Resonance Spectroscopy
11
Hematologic Tests
11
Exercise
11
Drug Therapy
11
Quality of Life
9
Biopsy
8
Specimen Handling
7
Therapeutics
6
Restraint, Physical
6
Magnetic Resonance Imaging
6
Focus Groups
6
pembrolizumab
5
Standard of Care
5
Rivaroxaban
5
Phlebotomy
5
Nivolumab
5
Lapatinib
5
Immune Checkpoint Inhibitors
5
atezolizumab
4
apixaban
4
Trastuzumab
4
Patient Reported Outcome Measures
4
Palliative Care
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Neoplasms
×
Defecation
×
Clear all
NCT04970472
2026-03-19
MicroBlad
University Hospital, Toulouse
Recruiting
1,000 enrolled
NCT04567446
2024-06-12
ONCOBIOTICS
Gustave Roussy, Cancer Campus, Grand Paris
Recruiting
1,100 enrolled